11/3/2022, 9:02 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Amgen

Amgen sees EPS soaring 20% to $3.98 in Q3

Amgen Inc. reported on Thursday its total revenues stood mostly unchanged in the third quarter of 2022 versus the same trimester a year ago at $6.7 billion. The company's operating income increased by about 12% to 2.7 billion in the same period, with GAAP earnings per share soaring 20% to $3.98. Results topped market expectations.

"This growth reflects the strong underlying demand for our medicines and the value they bring to patients," Chief Executive Robert Bradway noted in the report. Amgen revised its full-year guidance, saying it now expects revenue of up to $26.3 billion, as well as earnings per share of up to $12.17.

Amgen stock posted little gains in the after-hours trading following the results.

Baha Breaking News (BBN) / ND